President and Chief Executive Officer
Keith C. Valentine has served as our Chief Executive Officer since May 2015, our President since July 2015 and joined our Board of Directors in July 2015. Prior to joining SeaSpine, Mr. Valentine served as President and Chief Operating Officer of NuVasive, Inc. from January 2007 to January 2015 and as President from December 2004 to January 2007, prior to which he served in various senior executive roles in marketing, development and operations since joining NuVasive in 2001. Previously, Mr. Valentine served as Vice President of Marketing at ORATEC Interventions, Inc., a medical device company acquired by Smith & Nephew PLC, and spent eight years in various roles with Medtronic Sofamor Danek including, Vice President of Marketing for the Rods Division and Group Director for the BMP Biologics program, the Interbody Sales Development Effort, and International Sales and Marketing. Mr. Valentine currently serves on the Board of Directors of SI-BONE, Inc., a publicly traded medical device company focused on the treatment of musculoskeletal disorders of the sacro-pelvic anatomy, and serves as chair of its nominating and governance committee. Mr. Valentine received a B.B.A. in Management and Biomedical Sciences from Western Michigan University.
Senior Vice President, Chief Financial Officer
John J. Bostjancic has served as our chief financial officer since March 2015 and our treasurer since July 2015 and, in February 2018, was designated a senior vice president. Prior to this, Mr. Bostjancic served as acting chief financial officer of the SeaSpine business within Integra LifeSciences Holdings Corporation since December 2014. Prior to that, he was Integra’s senior vice president of global supply chain from February 2012 through November 2014, where he was responsible for global planning, kitting, distribution, logistics and customer service functions and led the project team implementing the U.S. Food and Drug Administration’s “unique device identifier” rule in 2014. From 2008 until January 2012, Mr. Bostjancic was senior vice president of financial planning & analysis at Integra. Since Mr. Bostjancic joined Integra in 1999, he held roles of increasing responsibility in the finance organization, including corporate controller from 2003 through 2006. Before joining Integra, Mr. Bostjancic was a manager in the accounting standards team at Merck & Co., Inc., a publicly traded global health care company, from 1998 through 1999 and worked in the business assurance organization at PricewaterhouseCoopers from 1993 through 1998. He received his B.S. in accounting from the College of New Jersey.
Senior Vice President, Global Spinal Systems
Dennis Cirino has served as our senior vice president, global spinal systems since July 2018. Mr. Cirino brings over 25 years of spine industry experience with numerous leadership roles in sales and marketing. Prior to joining SeaSpine, he was with NuVasive, Inc., a publicly traded medical device company, where he served in roles of increasing seniority, most recently serving as vice president of market development for computer-assisted surgery. Prior to NuVasive, Mr. Cirino spent ten years at Medtronic, four of which were in Switzerland, where he held senior marketing, development and marketing services positions focused on spinal systems, biologics, and pain stimulation. Mr. Cirino received a B.S./B.A. in Management Information Systems from Duquesne University and an M.B.A. from the University of Notre Dame.
Senior Vice President, General Counsel and Corporate Secretary
Patrick L. Keran has served as our general counsel since October 2015, secretary since June 2016 and, in June 2020, was designated a senior vice president. Prior to joining SeaSpine, Mr. Keran provided strategic and business advisory services to a variety of life sciences companies, including acting as Chief Legal Officer to NAIA Pharmaceuticals, Inc., a privately held international drug development company. From February 2010 to February 2015, Mr. Keran served as president and chief operating officer of Mast Therapeutics, Inc., a publicly held clinical stage biopharmaceutical company, and from August 2006 to February 2010, he served as its general counsel. He also served as Mast’s secretary from September 2006 to February 2015 and served as its principal financial officer from July 2009 to January 2013. Previously, from 2004 to 2006, Mr. Keran was associate general counsel at Ionis Pharmaceuticals, Inc. (formerly known as Isis Pharmaceuticals, Inc.), a publicly held drug discovery and development company. From 1999 to 2004, Mr. Keran practiced corporate law at the law firms of Heller Ehrman LLP and Brobeck Phleger & Harrison LLP, specializing in public and private financings, licensing arrangements, mergers and acquisitions and corporate governance matters. Mr. Keran is licensed to practice law in the State of California. Mr. Keran received a B.A. from the University of California at San Diego and a J.D. from the University of California at Berkeley, Boalt Hall School of Law.
Senior Vice President, Orthobiologics and Business Development
Tyler Lipschultz has served as our senior vice president, orthobiologics and business development since February 2018 and, from July 2015 to February 2018, served as our vice president, orthobiologics and business development. Before joining us, from June 2008 to March 2015, Mr. Lipschultz held positions of increasing responsibility at NuVasive, Inc., a publicly traded medical device company, most recently serving as its executive vice president, global operations and, prior to that, executive vice president, biologics. Prior to joining NuVasive, Mr. Lipschultz was a director at ProtoStar, a medical device incubator that formed Annulex, CVRx, and VERTx, which he co-founded. In 2002, VERTx merged with Spine Wave, where Mr. Lipschultz subsequently served in a variety of roles, including executive vice president and general manager of the mechanical business. Prior to ProtoStar, Mr. Lipschultz held the position of Equity Research Analyst at Piper Jaffray and served in various marketing/product management roles at Stryker, Smith & Nephew, and DePuy. Mr. Lipschultz received a B.A. in economics and business administration from Kalamazoo College and an M.B.A. from the executive program at Krannert School of Management at Purdue University.
Vice President, Regulatory and Quality Assurance
Laetitia Cousin serves as Vice President, Regulatory, Clinical and Quality Assurance. Prior to joining SeaSpine, Mrs. Cousin spent 16 years in progressively senior positions at NuVasive. Most recently, she served as NuVasive’s Vice President, Regulatory and Clinical Affairs, Quality Assurance. Mrs. Cousin has nearly two decades of medical technology experience, primarily in regulatory affairs, quality assurance, and premarket clinical studies and has demonstrated excellence in scaling, influencing, and strategically guiding global regulatory, quality and clinical teams in the spinal device and tissue industry. Mrs. Cousin received a B.S. in biological sciences from the Florida Institute of Technology.
General Manager of Process Innovation and Development
Bill Rhoda has served as our General Manager of Process Innovation and Development since December 2016. Mr. Rhoda has a long history in the spinal implant space, starting his career in orthopedics with Synthes Spine in the late 90’s as a product development engineer. Mr. Rhoda later became a founding member of Globus Medical, serving as the Vice President of Product Development. While there, he conceived and implemented a rapid product development process that dramatically shortened the time from concept to market introduction from 2+ years to 12 months. Since leaving Globus in 2012, Mr. Rhoda has helped form and develop new and innovative companies as well as created his own medtech venture capital firm. The firm now has six portfolio companies within its investment structure. Mr. Rhoda also serves on the boards of various medical device companies.
Vice President, Orthobiologics Research & Development, and Clinical Affairs
Frank Vizesi joined SeaSpine in September 2015 and serves as our Vice President, Orthobiologics Research & Development, and Clinical Affairs. Dr. Vizesi is responsible for research and product development of our orthobiologics portfolio, as well as clinical research for all of SeaSpine. Dr. Vizesi has dedicated his career to the orthobiologics space and has developed and launched multiple orthobiologics products supported by basic science and clinical research. Prior to joining SeaSpine, Dr. Vizesi spent 8 years at NuVasive in leadership positions of increasing responsibility and played a pivotal role in growing its Biologics franchise from essentially zero to in excess of $100 million in annual revenue. Dr. Vizesi completed his Ph.D. in Biomedical Engineering, M.E. in Biomedical Engineering and B.E. in Mechanical Engineering from the University of New South Wales in Sydney, Australia.
Vice President, Sales
John J. Winge has served as our vice president, sales since June 2015. From August 2008 to June 2015 he served as vice president, sales of the U.S. spine division of Integra LifeSciences Holdings Corporation. He was also vice president, marketing for Integra’s U.S. spine division from June 2011 to September 2013. Mr. Winge joined Integra in August 2008 when Integra acquired Theken Spine, LLC, a privately held medical device company focused on spine, where Mr. Winge served as executive vice president, sales and played an integral role in building Theken Spine from approximately $6 million to roughly $50 million in annual revenue. Prior to joining Theken Spine in 2004, Mr. Winge led the distribution business for REO Spine as the U.S. distributor for Eurosurgical Ltd., a distributor of surgical instrumentation and medical equipment products, from 1999 to 2004. Mr. Winge worked with various independent distributors from 1992 to 1998 as a spine hardware sales representative and manager. Mr. Winge began his medical device career as a sales representative for Sofamor Danek. Mr. Winge received a B.A. in economics from the University of Pittsburgh.
Vice President, Marketing
Troy Woolley serves as our Vice President, Marketing. Prior to joining SeaSpine, Mr. Woolley served medical device companies in the strategic marketing and development of surgical products and procedures as a consultant, and held roles with Lanx - Biomet Spine as Vice President of Marketing and Vice President of Medical Education and Sales Training. Previously, Mr. Woolley spent 13 years with NuVasive in leadership roles in marketing and product development contributing to revenue growth from $0 to over $600 million. His achievements include the successful development, launch and commercialization of XLIF and several other novel minimally disruptive spine procedures. Mr. Woolley received a B.S. and M.S. in mechanical engineering from University of California, San Diego.